Laura Beretta, PhD, is Professor in the Department of Molecular and Cellular Oncology at MD Anderson Cancer Center, Houston. She has been actively involved in HUPO and USHUPO. In particular, she is serving as co-chair of the HUPO liver proteome project. Her research interest is liver cancer early detection and prevention. Her lab generated extensive information on proteome changes occurring during liver fibrosis, steatosis and hepatocellular carcinoma (HCC). This approach was applied to both liver and plasma and led to the identification of novel biomarkers for early detection of HCC. Novel targets for HCC prevention were also identified and are currently tested in mouse models.
“Comparative Proteomics in Hepatocellular Carcinoma: Functional Insights and Translational Implications”